International Society for Heart and Lung Transplantation
ROADMAP: LVAD improved survival, functional status in patients with advanced HF
Left ventricular assist device therapy was associated with improved survival and functional status at 1 year compared with optimal medical management in patients with advanced HF, according to new data from the ROADMAP study presented at the International Society for Heart and Lung Transplantation Annual Meeting and Scientific Sessions.
ENDURANCE: Stroke-free survival similar with centrifugal-flow VAD, LVAD
Patients with advanced HF ineligible for heart transplantation who were implanted with a centrifugal-flow ventricular assist device system or an axial-flow left ventricular assist device had similar rates of stroke-free survival at 2 years, according to data from the ENDURANCE trial presented at the International Society for Heart and Lung Transplantation Annual Meeting and Scientific Sessions.